Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis by Asumendi, A et al.
Implication of mitochondria-derived ROS and cardiolipin
peroxidation in N-(4-hydroxyphenyl)retinamide-induced
apoptosis
A Asumendi*
,1, MC Morales
1, A Alvarez
1, J Are ￿chaga
1 and G Pe ￿rez-Yarza
1
1Department of Cell Biology and Histology, School of Medicine and Dentistry, University of The Basque Country, Leioa- 48940, Bizkaia, Spain
{ We have studied the effect of N-(4-hydroxyphenyl)retinamide on either malignant human leukaemia cells or normal cells and
investigated its mechanism of action. We demonstrate that 4HPR induces reactive oxygen species increase on mitochondria at
a target between mitochondrial respiratory chain complex I and II. Such oxidative stress causes cardiolipin peroxidation which
in turn allows cytochrome c release to cytosol, caspase-3 activation and therefore apoptotic consumption. Moreover, this
apoptotic pathway seems to be bcl-2/bax independent and count only on malignant cells but not normal nor activated
lymphocytes.
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Recently, retinoids have generated interest as potential therapeutic
and preventive agents for the treatment of cancer. Among the
synthetic retinoids with minimal clinical toxicity, N-(4-hydroxy-
phenyl)retinamide (4HPR), also named fenretinide, has emerged
as one of the most promising alternatives to the natural–more
toxic–retinoids. 4HPR inhibits carcinogenesis and has therapeutic
effects in a variety of animal cancer models. Trials in humans are
also presently under way with 4HPR (Ulukaya and Wood, 1999).
These anticancer activities seem to be related with their ability in
vitro to inhibit tumour cell growth and to induce apoptosis (Delia
et al, 1993; Kalemkerian et al, 1995). Recently, reactive oxygen
species (ROS) have been implicated in the mediation of apoptosis
by 4HPR in human cancer cells (Delia et al, 1997; Maurer et al,
1999; Suzuki et al, 1999; Hail and Lotan, 2001), but at least one
mechanism independent to ROS, which involved RAR-mediated
pathway, has also been reported to be involved (Sun et al, 1999).
Accumulating evidence points to a central role of mitochondria
during apoptosis. Alterations in mitochondrial physiology, such as
dissipation of the inner transmembrane potential and/or release of
intermembrane proteins through the outer membrane, have been
described in many apoptotic responses (Loefﬂer and Kroemer,
2000). Among the released proteins, caspases (mainly 2, 3 and
9), caspase activators (cytochrome c, hsp10) as well as a caspase-
independent death effector AIF (apoptosis inducing factor) have
been identiﬁed, and they are ultimately responsible for apoptotic
cell consumption (Loefﬂer and Kroemer, 2000).
In this study, we contribute with new data to the mechanisms by
which 4HPR induces cell death in cancer cells, involving cardioli-
pin peroxidation as the cause of cytochrome c release and
caspase-3 activation.
MATERIALS AND METHODS
Cell cultures and isolation of peripheral lymphocytes
CCRF–CEM human acute lymphoblastoid leukaemia cells were
routinely grown in RPMI 1640 supplemented with 10% heat inac-
tivated foetal calf serum (FCS), 100 mgm l
71 gentamicine and
2m ML -glutamine. Human peripheral blood mononuclear cells
from normal volunteers were obtained after Ficoll-Paque (Pharma-
cia LKB, Uppsala, Sweden) density gradient centrifugation and
differential adhesion. Cells were cultured in 10% FCS and RPMI
1640 containing L-glutamine, 50 mM 2-Mercaptoethanol. To obtain
activated lymphocytes, 20 mgm l
71 phytohemagglutinin-M (Roche
Molecular Biochemicals) were added to culture, proliferating cells
were collected after 48 h, washed and seeded at 1610
6 cells ml.
Cell survival assay
A standard XTT assay (Roche Molecular Biochemicals, IN, USA)
was used to determine cell survival. Cells were plated in 96-well
plates at a density of 1610
6 cells per ml (four wells per experimen-
tal condition), exposed to a range of concentrations of 4HPR and
processed according to the manufacturer’s instructions. In some
experiments, 10 mM N-acetyl-cysteine (NAC) or 100 mM vitamin
E (Sigma) were added 2 h before 4HPR addition. Absorbance at
480 nm was determined for each well, and cell survival percentages
were calculated in each experiment in relation to controls–non
treated–cells.
Flow cytometry
The Annexin V-FITC apoptosis detection kit (Calbiochem, Onco-
gene) was used to distinguish between apoptosis and necrosis.
Cells were labelled after treatments according to the manufacturer’s
instructions and analysed by ﬂow cytometry. Viable cells do not
bind Annexin V-FITC or propidium iodide. Early apoptotic cells
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www.bjcancer.combind Annexin V-FITC but exclude propidium iodide. Necrotic and
apoptotic cells in terminal stages (secondary necrosis) are both
Annexin V-FITC and propidium iodide positive. Reduction of
mitochondrial membrane potential was evaluated by Rhodamine
123 labelling (Molecular Probes, Eugene, OR, USA). After drug
exposure cells were incubated with 5 mgm l
71 Rh 123 in RPMI
1640 containing 10% FCS for 30 min at 378C. Then cells were
washed twice with PBS and incubated for 30 min with 10% FCS
RPMI 1640. After washing, 5 mgm l
71 IP were added and viable
cells were analysed by ﬂow cytometry. At least 10000 viable cells
per sample were individually analysed for quantitative ﬂuorescence
using a Coulter EPICS ELITE ESP ﬂow cytometer (EPICS division
Coulter Corp.).
Western blotting
Pellets were resuspended in Laemmli’s SDS–PAGE sample buffer
to a 16 and the viscosity of the lysates was reduced by shearing
the DNA three times through a 26 needle. After boiling for
5 min, 30 mg of each protein samples were subjected to electro-
phoresis in 15% polyacrylamide gels in the presence of 0.1%
sodium dodecyl sulphate and transferred to nitrocellulose
membranes. The nonspeciﬁc binding sites on the membrane were
ﬁrst blocked with 5% (w v
71) dried milk in 20 mM Tris-HCl
(pH 8.0) containing 0.1% (v v
71) Tween 20 (TTBS) for 1 h at
room temperature. After three washes with TTBS, the membrane
was incubated with anti-caspase-3, anti-bcl-2 (Santa Cruz Biotech-
nology, Inc., CA, USA) or anti-bax (R&D Systems Minneapolis,
MN, USA) antibodies diluted 1:100 in 2.5% (w v
71) dried milk
in TTBS for 90 min at room temperature. The membranes were
then washed three times in TTBS, and incubated with anti-mouse
or anti-rabbit IgG-peroxidase conjugate diluted 1:3000 in 1%
(w v
71) dried milk in TTBS for 1 h at room temperature. The
membrane was then washed four times with TTBS. The binding
of the antibodies were probed by the chemiluminescence ECL
method according to the manufacturer’s instructions (Amersham
Life Science Inc., Arlington Heights, IL, USA). For the detection
of cytochrome c release from mitochondria, cytosolic extracts were
used. After treatments, cells were centrifugated, resuspended in
buffer I (220 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH
pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2,1 m M DTT)
and placed on ice during 10 min. Cells were centrifugated at
1000 g for 5 min and then 30 ml of buffer I supplemented with
leupeptin 1 mgm l
71, aprotinin 1 mgm l
71, and pepstatin
1 mgm l
71 were used to suspend the cells. The cells were then
disrupted by homogenisation on ice in a teﬂon dounce (100
strokes), the homogenate was subjected to centrifugation at
16000 g for 1 min, and then the supernatant was collected and
subjected to another centrifugation at 16000 g for 30 min to
obtain a cytosolic extract. Samples of the cytosolic extracts contain-
ing 40 mg protein were subjected to electrophoresis using 15%
polyacrylamide gel, transferred and developed as described. Anti-
cytochrome c monoclonal antibody was purchased by BD Phar-
mingen (San Diego, CA, USA) and used at 1:500 dilution.
Measurement of intracellular generation of ROS
We used the oxidation-sensitive ﬂuorescent dye 2',7 '-dichlorodihy-
droﬂuorescein diacetate (DCFH-DA, Molecular Probes, Eugene,
OR, USA) to measure the production of reactive oxygen species,
mainly hydrogen peroxide and hydroxyl radicals. Cells seeded in
96-well culture plates were exposed to 4HPR alone or in combina-
tion with antioxidants. Vitamin E (100 mm) or NAC (10 mM) were
added 2 h before the drug. In some cultures (see Figure 6) the
following inhibitors were added in combination with 4HPR: the
uncoupler, carbonylcyanide m-chlorophenylhydrazone (CCCP)
10 mM; NADPH inhibitor DPI 2 mM; xanthine/xanthine oxidase
inhibitor, allopurinol 1 mM; MRC complex II inhibitor, thenoyltri-
ﬂuoroacetone (TTFA) 1 mM; MRC complex III inhibitor,
antimycin A 2 mgm l
71 (all were purchased from Sigma Chemical
Co). After 30 min cells were washed and incubated at 378C with
10 mgm l
71 DCFC-DA for 20 min. After washing twice, ﬂuores-
cence intensity was measured at 530 nm after excitation at
485 nm in a FL500 ﬂuorimeter (Bio-Tek Instruments). Four wells
were used for each treatment.
Measurement of cardiolipin peroxidation
10-N-nonyl-Acridin Orange (NAO, Molecular Probes, Inc.), which
binds to mitochondria-speciﬁc cardiolipin, was used for this
purpose. Decreases in the ﬂuorescence of NAO in apoptotic cells
have been reported to reﬂect the peroxidation of intracellular
cardiolipin (Nomura et al, 2000) because the ﬂuorochrome loses
its afﬁnity for peroxidised cardiolipin. Cells were seeded at a ﬁnal
concentration of 1610
6 cells ml
71 in 96-well tissue culture plates,
treated with different concentrations of 4HPR, washed and labelled
with 10 mgm l
71 NAO for 20 min. In some cultures 100 mM vita-
min E was added 2 h before 4HPR addition. After washing twice,
ﬂuorescence emited by cardiolipin-bounded NAO was measured at
530 nm–excitation at 485 nm–in a FL500 ﬂuorimeter (Bio-Tek
Instruments). Four wells were used for each experimental condi-
tion.
Statistics
The results were expressed as the mean+s.d of at least three inde-
pendent experiments. Student’s two-tailed, unpaired t-test was
used, and values of P 50.05 were considered to be signiﬁcant.
RESULTS
A dose–time study was carried out to establish the effect of 4HPR
in the survival rate of CCRF–CEM cells (Figure 1). The lower
concentration in which maximum cell death was achieved was
3 mM, a concentration known to be attainable in vivo (Formelli et
al, 1993). At this dose, nearly 90% of the cells were eliminated
in 24 h. However, neither normal nor activated peripheral lympho-
cytes were affected under these conditions (Figure 2). Only the
maximum concentration tested–10 mM 4HPR–had some effect
on the survival of normal lymphocytes, being the latter much more
resistant to the drug than malignant cells.
4HPR-induced cell death in lymphoblastoid leukaemia cells is
caused by apoptosis at pharmacological concentrations (Figure
3A), but proceeds predominantly by necrosis at higher drug
concentrations (10 mM). Ultrastuctural images have conﬁrmed that
the enhancement of necrosis percentages is mainly due to second-
ary necrosis (apoptotic cells in terminal stages) rather than real
necrosis. These results are in concordance with the observation that
caspase 3 is activated in cells treated with 4HPR (Figure 3B). The
blot revealed a progressive cleavage of pro-caspase 3 in the course
of time. However, no changes in the expression of apoptosis-
related proteins Bcl-2 and Bax have been observed (Figure 3C).
Measurements of cellular ﬂuorescence revealed that 4HPR
induced an immediate ROS elevation in CCRF–CEM cells. After
30 min of exposure, a dose-dependent increase in the amount of
ROS was observed (Figure 4). The enhancement of ROS was much
higher after 45–60 min of exposure when 4.0-fold increase in ROS
was observed at higher doses, and was noticeable just after 5 min
of treatment (data not shown). This oxidative stress was inhibited
with antioxidants such as N-acetyl-cysteine (NAC) and vitamin E,
being the latter more effective at neutralising reactive oxygen
species (Figure 4). These antioxidants that are effective at suppres-
sing HPR-induced ROS are also effective at reducing 4HPR-
induced apoptosis (Figure 5). Curiously, vitamin E–which is more
powerful than NAC scavenging ROS generated by 4HPR–is also
more effective at reducing drug induced cell death. In this sense,
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British Journal of Cancer (2002) 86(12), 1951–1956 ã 2002 Cancer Research UKvitamin E is able to completely inhibit cell death induced by 1 mM
of 4HPR, and reverts from 10 to 75% the cell death induced by
3 mM 4HPR. Results indicate that the antioxidants effect on
HPR-induced apoptosis is related with their ability to suppress
the enhancement of ROS in 4HPR-treated malignant cells. In
contrast, our assays failed to prove enhancement of ROS on
4HPR-treated normal and activated peripheral lymphocytes (data
not shown).
To analyse the origin of 4HPR-induced reactive oxygen species,
the effect of some radical-producing system inhibitors was tested in
the presence of 4HPR (Figure 6). Allopurinol–xanthine/xanthine
oxidase inhibitor–and DPI–NADPH oxidase inhibitor-, have no
effect on 4HPR-induced ROS increase. However, CCCP, which
uncouples electron transfer in mitochondria and inhibits the
generation of ROS from MRC, suppressed completely 4HPR-
induced oxidative stress. Among the inhibitors of MRC complexes
tested, only TTFA–an MRC complex II inhibitor–completely
suppressed 4HPR-induced ROS elevation. The MRC complex I
inhibitor rotenone inhibited 4HPR-induced ROS generation by
52%, but none of the other inhibitors used (antimycin A which
inhibits complex III and azide which inhibits complex IV) caused
any effect over the ROS production. These results indicate that
4HPR stimulated ROS production upstream of complex III, prefer-
entially between complexes II and III.
To study if peroxidation of cardiolipin (CL) took place in
4HPR-treated cells, binding of NAO–a ﬂuorescent probe that
binds speciﬁcally to CL–was measured in treated CEM cells (Table
1). Results showed a dose- and time-dependent decrease of NAO
binding to 4HPR-treated cells (Table 1), which reﬂect the peroxi-
dation of mitochondrial CL. Fluorochrome binding reduction
was signiﬁcant after 2 h of 4HPR-treatment with reference to
non treated cells, and a decrease of 50–60% in NAO binding
was observed at high doses (10 mM). At lower doses (3 mM), about
50% of NAO binding capacity to CL is lost as early as at 6 h of
exposure. The antioxidant vitamin E reduces CL peroxidation in
all cases, and it is more effective preventing the oxidation induced
by lower doses of 4HPR. It is important to note that mitochondrial
transmembrane potential reduction–measured by Rhodamine 123
labelling–was not observed until 4 h after exposure to drug
(Figure 7). Thus, CL peroxidation precedes mitochondrial potential
reduction.
4HPR induces a release of cytochrome c from mitochondria in
CEM cells and the amount of cytochrome c detected in the cytosol
was increasing along the 4HPR-treatment time (0, 2, 8 and 12 h)
(Figure 8). Moreover, this release is clearly reduced in all cases
when the vitamin E is added to the cultures. This result shows that
4HPR induces cytochrome c release in an antioxidant-sensitive
pathway.
DISCUSSION
Our results indicate that at pharmacological doses, 4HPR causes
apoptosis in human acute lymphoblastoid leukaemia cells
CCRF–CEM (Figure 3A,B), and that its proapoptotic properties
are related with the ability to produce ROS at mitochondrial level.
The increase in ROS has been proposed as one mechanism through
which 4HPR could exert its proapoptotic effects (Delia et al, 1997;
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Figure 1 Dose- and time-dependent effect of 4HPR on cell survival of
human CCRF–CEM cells. The mean+s.d of three independent experi-
ments are shown.
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Figure 3 (A) Apoptosis and necrosis rates in 4HPR-treated CCRF–
CEM cells. Cells were treated with increasing doses of 4HPR for 8, 12
and 24 h and then labelled with Annexin-V and Propidium Iodide as
described in Materials and Methods. Apoptosis percentages are repre-
sented in grey, and in black percentages of necrotic cells in the same cul-
tures. (B) Activation of caspase-3 in 4HPR-treated human CCRF–CEM
cells. Blot shows the progressive pro-caspase-3 cleavage along time in
10 mM 4HPR-treated cells. (C) Bcl-2 and Bax protein expression in control
and 4HPR-treated CEM cells.
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that antioxidants NAC and vitamin E decrease both 4HPR-induced
ROS production (Figure 4) and cell death (Figure 5), demonstrate
that ROS are critical in mediating apoptosis in CEM cells. Also,
our studies revealed that 4HPR exerts different effects on either
malignant lymphoblasts or normal lymphocytes. 4HPR does not
stimulate ROS production on normal or activated peripheral
lymphocytes, and subsequently these cells seem to be signiﬁcantly
more resistant to 4HPR than tumour cells (Figure 2). This speciﬁ-
city of retinamide towards malignant cells and not normal cells
confers 4HPR an important characteristic as a therapeutic agent.
The more or less sensitivity of cells to 4HPR may be due to the
status of endogenous antioxidant systems. The major source of
ROS in eukariotic cells are the mitochondrial respiratory chain
components (Ferna ￿ndez-Checa et al, 1998), and the radical-gener-
ating enzymes xanthine/xanthine oxidase (McCord, 1985) and
NADPH oxidase (Trudel et al, 1991). Among all inhibitors of such
ROS source used, only those exerting their action on mitochondria
have some effect on the 4HPR-induced oxidative stress (Figure 6).
Blocking ATP synthesis and ROS generation by MRC with CCCP–
an uncoupler of electron transfer–4HPR-induced oxidative stress
is completely reduced, which indicates mitochondrial participation.
In this sense Hail and Lotan (2001) have demonstrated recently
that the pro-oxidant effect of 4HPR is associated with mithochon-
drial redox metabolism in human cutaneous carcinoma cells. To
reinforce the ﬁnding that electron ﬂow at MRC is the major site
of ROS generation by 4HPR, we inhibited electron ﬂow at
complexes I to IV, and the results illustrated that ROS generation
source is probably located downstream MRC complexes I and II,
and upstream complex III (Figure 6). These results are in accor-
dance with those reported by Suzuki et al (1999) in cervical
carcinoma cells, which point to a target site of 4HPR action in
ROS generation located between complexes II and III. Additional
studies are required to determine whether ROS increase at these
sites is a general phenomenon or not in 4HPR-induced apoptosis.
Nowadays it is generally accepted that alterations of the mito-
chondrial function, such as a reduction of the inner
transmembrane potential and release of proteins through the outer
membrane, constitute an important feature of apoptosis. Our
studies show that in 4HPR treated cells, ROS enhancement–
perceptible just after 5 min but signiﬁcant after 30 min–is gener-
ated earlier than mitochondrial membrane reduction (observed
after 4 h, Figure 7). Therefore, it is likely that mitochondrial altera-
tions observed are due to the direct action of 4HPR-induced ROS.
ROS are able to open mitochondrial transition pores leading to an
interruption of mitochondrial potential and release of apoptogenic
factors (Kroemer et al, 1997). However, the mechanism responsible
is not deﬁned. Pro- and anti-apoptotic members of the Bcl-2
family can control the mitochondrial transition pores in some
systems (Loefﬂer and Kroemer, 2000). No participation of Bcl-2/
Bax in 4HPR-induced cell death was observed in our studies
(Figure 3C). Expression of other proteins tested such as Bak and
Bcl-xl also remain unaltered in 4HPR-treated CEM cells (data
not shown). Lipid peroxidation, which is known to occur during
cell death after stimulation with pro-oxidants (Ferna ￿ndez-Checa
et al, 1998; Nomura et al, 2000), could be one of the causes that
originate mitochondrial dysfunction. Our results show that
4HPR-induced mitochondrial ROS increase is the cause of cardio-
lipin peroxidation as early as 2 h after 4HPR treatment (Table 1),
before reduction of mitochondrial membrane potential was evident
(Figure 7). Cardiolipin–which is located exclusively in the inner
mitochondrial membrane–, has a pivotal role as the boundary
lipid of various proteins such as NADH:ubiquinone oxidoreduc-
tase, cytochrome c oxidase and cytochrome c (Hoch, 1992).
Speciﬁcally, cytochrome c associates strongly with cardiolipin. A
linkage between mitochondrial lipid peroxidation and cytochrome
c release has been recently established (Nomura et al, 2000).
Nomura et al (2000) have shown that peroxidation of CL in the
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British Journal of Cancer (2002) 86(12), 1951–1956 ã 2002 Cancer Research UKmitochondria resulted in the dissociation of cytochrome c from
mitochondrial inner membranes, the initial step in the release of
cytochrome c to cytosol. Furthermore, cardiolipin is essential for
the activity of ANT (adenine nucleotide translocator) (Hoffmann
et al, 1994), a protein of permeability transition pores, and there-
fore cardiolipin peroxidation could explain why ROS are able to
open the mitochondrial permeability transition pores. Release of
cytochrome c, which occurs following a variety of death stimuli,
has been shown to activate Apaf-1 (apoptotic protease-activating
factor 1), which in turn activates caspases-9 and -3 (Li et al,
1997; Zou et al, 1997) that ﬁnally dismantle the cell. It now seems
likely that cardiolipin peroxidation caused by 4HPR-induced ROS
(Table 1) triggers cytochrome c release (Figure 7) and, in conse-
quence, the observed caspase-3 activation (Figure 3). Reinforcing
this idea is the ﬁnding that vitamin E–whose major function is
to protect the polyunsaturated membrane lipids against free radical
attack–appears to be more effective against 4HPR-induced apop-
tosis than other antioxidants tested (Figure 5). Furthermore, we
have demonstrated that Vitamin E was able to reduce clearly the
CL peroxidation (Table 1) and cytochrome c release (Figure 7)
in 4HPR-treated cells and therefore, these events occurred later
than ROS generation. However, we cannot exclude the possibility
that other actions of ROS–different from that concerning mito-
chondria membranes–contribute to caspase activation and
therefore to 4HPR-induced cell death.
In summary, our results suggest a linkage between ROS genera-
tion at the MRC (between complexes II and III), cardiolipin
peroxidation, cytochrome c release and caspase-3 activation in
4HPR-induced apoptosis.
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peroxidation. Differences in NAO binding of antioxidant-treated cells were statistically signiﬁcant with respect to those
only treated with 4HPR (*P50.05).
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Figure 7 Mitochondrial membrane potential in CCRF-cells treated with
4HPR. Cells treated with 6 mgm l
71 4HPR during short periods of time (1,
3 and 4 h) were labelled with Rhodamine 123 and analysed by ﬂow cyto-
metry. The reduction of transmembrane potential after 4 h of treatment is
represented as a shift of the ﬂuorescence peak to lower levels and the per-
centage of cells in the lower ﬂuorescence category was plotted in the
graphs.
Vit E – – + – + – +
4HPR – 2 h 8 h 12 h
Figure 8 Effect of vitamin E on 4HPR-induced cytochrome c release in
human CCRF–CEM cells. Cells were incubated without (control) or with
5 mM 4HPR during 2, 8 and 12 h. In some cultures vitamin E was added 2 h
before addition of 4HPR.
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